0% found this document useful (0 votes)
12 views21 pages

API MultiProduct QRA 20slides

The document outlines a Quality Risk Assessment (QRA) framework for Active Pharmaceutical Ingredients in multiple product manufacturing plants, based on ICH Q9 principles. It details the purpose of QRA, which includes identifying and controlling risks to ensure compliance with cGMP and product quality. The methodology includes steps for risk identification, analysis, evaluation, control, and review, emphasizing continuous monitoring and improvement.

Uploaded by

Vinay Patel
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
12 views21 pages

API MultiProduct QRA 20slides

The document outlines a Quality Risk Assessment (QRA) framework for Active Pharmaceutical Ingredients in multiple product manufacturing plants, based on ICH Q9 principles. It details the purpose of QRA, which includes identifying and controlling risks to ensure compliance with cGMP and product quality. The methodology includes steps for risk identification, analysis, evaluation, control, and review, emphasizing continuous monitoring and improvement.

Uploaded by

Vinay Patel
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd

Quality Risk Assessment for

Active Pharmaceutical
Ingredients
(Multiple Product Manufacturing
Plant)
Based on ICH Q9 Quality Risk
Management Principles
Introduction
• Overview of QRA for API manufacturing plants
producing multiple products.
Purpose of QRA
• - Identify, evaluate, and control risks
• - Ensure compliance with cGMP
• - Minimize cross-contamination
• - Assure product quality, safety, and efficacy
Scope
• - Covers processes, equipment, facilities,
utilities, personnel
• - Addresses changeovers, cleaning validation,
material handling
ICH Q9 Principles
• Risk management framework for
pharmaceutical manufacturing.
Methodology Step 1: Identification
• List all potential hazards impacting product
quality.
Methodology Step 2: Analysis
• Assess severity, probability, and detectability
of risks.
Methodology Step 3: Evaluation
• Determine RPNs and rank risks.
Methodology Step 4: Control
• Implement engineering, procedural, and
administrative measures.
Methodology Step 5: Review
• Ensure continuous monitoring and
reassessment.
Risk Example: Cross-Contamination
• Hazard: Product residues between batches
• Control: Dedicated equipment, validated
cleaning
Risk Example: Label Mix-up
• Hazard: Incorrect labeling
• Control: Barcoding, line clearance
Risk Example: Cleaning Validation
• Hazard: Ineffective cleaning
• Control: Validation protocols, revalidation
Risk Example: Equipment Failure
• Hazard: Downtime and contamination
• Control: Preventive maintenance
Risk Example: Personnel Gowning
• Hazard: Contamination from personnel
• Control: Training, supervision
Risk Ranking
• Severity (S) × Probability (P) = RPN
• Higher RPN = Higher Priority
Risk Control Measures
• - Engineering controls
• - Administrative controls
• - Procedural improvements
Risk Review Frequency
• Annual review or after significant change in
processes
Benefits of QRA
• - Enhanced compliance
• - Reduced contamination risk
• - Improved safety and quality
Conclusion
• Proactive QRA implementation ensures
consistent product quality.
Final Note
• Risk management is a continuous
improvement process.

You might also like